{"id":"https://openalex.org/W2807875714","doi":"https://doi.org/10.1159/000488202","title":"Overall Survival Benefit from Trastuzumab-Based Treatment in HER2-Positive Metastatic Breast Cancer: A Retrospective Analysis","display_name":"Overall Survival Benefit from Trastuzumab-Based Treatment in HER2-Positive Metastatic Breast Cancer: A Retrospective Analysis","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2807875714","doi":"https://doi.org/10.1159/000488202","mag":"2807875714","pmid":"https://pubmed.ncbi.nlm.nih.gov/29902791"},"language":"en","primary_location":{"id":"doi:10.1159/000488202","doi":"https://doi.org/10.1159/000488202","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000488202","pdf_url":null,"source":{"id":"https://openalex.org/S2769437601","display_name":"Oncology Research and Treatment","issn_l":"2296-5262","issn":["2296-5262","2296-5270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Research and Treatment","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091483766","display_name":"Shuzhen Lv","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210154593","display_name":"Beijing Shijitan Hospital","ror":"https://ror.org/0569k1630","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210154593"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuzhen Lv","raw_affiliation_strings":["Department of Breast Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210154593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101842128","display_name":"Yunchao Wang","orcid":"https://orcid.org/0000-0002-3702-3826","observed_orcids":["https://orcid.org/0000-0002-3702-3826"]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210147433","display_name":"Beijing Friendship Hospital","ror":"https://ror.org/053qy4437","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210147433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yunchao Wang","raw_affiliation_strings":["Department of Gerontology, Beijing Friendship Hospital, Capital Medical University, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gerontology, Beijing Friendship Hospital, Capital Medical University, Beijing, China","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210147433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061832044","display_name":"Tao Sun","orcid":"https://orcid.org/0000-0001-8062-3432","observed_orcids":["https://orcid.org/0000-0001-8062-3432"]},"institutions":[{"id":"https://openalex.org/I4210161255","display_name":"Liaoning Cancer Hospital & Institute","ror":"https://ror.org/05d659s21","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210161255"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tao Sun","raw_affiliation_strings":["Department of Internal Oncology, Liaoning Cancer Hospital and Institute, Shenyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Oncology, Liaoning Cancer Hospital and Institute, Shenyang, China","institution_ids":["https://openalex.org/I4210161255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015794251","display_name":"Donggui Wan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801051648","display_name":"China-Japan Friendship Hospital","ror":"https://ror.org/037cjxp13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801051648"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Donggui Wan","raw_affiliation_strings":["Department of Oncology, China-Japan Friendship Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, China-Japan Friendship Hospital, Beijing, China","institution_ids":["https://openalex.org/I2801051648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070019239","display_name":"Lijun Sheng","orcid":"https://orcid.org/0000-0002-8240-9736","observed_orcids":["https://orcid.org/0000-0002-8240-9736"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lijun Sheng","raw_affiliation_strings":["Department of Oncology, Shandong Cancer Hospital, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Shandong Cancer Hospital, Jinan, China","institution_ids":["https://openalex.org/I4210100830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318325","display_name":"W\u011bi Li","orcid":"https://orcid.org/0000-0002-9522-4474","observed_orcids":["https://orcid.org/0000-0002-9522-4474","https://orcid.org/0000-0003-4136-3409","https://orcid.org/0009-0009-9141-6389"]},"institutions":[{"id":"https://openalex.org/I4210152119","display_name":"Jiangsu Province Hospital","ror":"https://ror.org/04py1g812","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210152119"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["Department of Oncology, the First Af\ufb01liated Hospital of Nanjing Medical University, Nanjing, China;","Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, the First Af\ufb01liated Hospital of Nanjing Medical University, Nanjing, China;","institution_ids":["https://openalex.org/I4210152119"]},{"raw_affiliation_string":"Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China","institution_ids":["https://openalex.org/I4210152119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112780324","display_name":"Huayun Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128482","display_name":"Jiangsu Cancer Hospital","ror":"https://ror.org/03108sf43","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210128482"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huayun Zhu","raw_affiliation_strings":["Department of Oncology, Jiangsu Cancer Hospital of Nanjing Medical University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Jiangsu Cancer Hospital of Nanjing Medical University, Nanjing, China","institution_ids":["https://openalex.org/I4210128482","https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100385638","display_name":"Yanping Li","orcid":"https://orcid.org/0000-0002-3102-4051","observed_orcids":["https://orcid.org/0000-0002-3102-4051"]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210154593","display_name":"Beijing Shijitan Hospital","ror":"https://ror.org/0569k1630","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210154593"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yanping Li","raw_affiliation_strings":["Department of Breast Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210154593"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032612608","display_name":"Janice M. Lu","orcid":"https://orcid.org/0009-0006-8926-6367","observed_orcids":["https://orcid.org/0009-0006-8926-6367"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210154593","display_name":"Beijing Shijitan Hospital","ror":"https://ror.org/0569k1630","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210154593"]}],"countries":["CN","US"],"is_corresponding":false,"raw_author_name":"Janice Lu","raw_affiliation_strings":["Department of Breast Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China","Division of Hematology and Medical Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210154593"]},{"raw_affiliation_string":"Division of Hematology and Medical Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6429,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.71217292,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"41","issue":"7-8","first_page":"450","last_page":"455"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.972000002861023},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9959999918937683},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.777999997138977},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.8799999952316284},{"id":"https://openalex.org/keywords/visceral-metastasis","display_name":"visceral metastases","score":0.996999979019165},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8090000152587891},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.675000011920929}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9771794080734253},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8961528539657593},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7859009504318237},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7518348693847656},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7436866164207458},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.659304678440094},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5272741913795471},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4484184980392456},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3986947238445282}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000488202","doi":"https://doi.org/10.1159/000488202","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000488202","pdf_url":null,"source":{"id":"https://openalex.org/S2769437601","display_name":"Oncology Research and Treatment","issn_l":"2296-5262","issn":["2296-5262","2296-5270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Research and Treatment","raw_type":"journal-article"},{"id":"pmid:29902791","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29902791","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology research and treatment","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1531524380","https://openalex.org/W1981701117","https://openalex.org/W2000269004","https://openalex.org/W2031366588","https://openalex.org/W2043348423","https://openalex.org/W2043506695","https://openalex.org/W2111578514","https://openalex.org/W2123591186","https://openalex.org/W2137853125","https://openalex.org/W2141546964","https://openalex.org/W2164394286","https://openalex.org/W2165824128","https://openalex.org/W2318605753","https://openalex.org/W2414528910"],"related_works":["https://openalex.org/W2124414372","https://openalex.org/W2515028737","https://openalex.org/W2624795029","https://openalex.org/W2141546964","https://openalex.org/W2589486574","https://openalex.org/W2593702223","https://openalex.org/W2333483292","https://openalex.org/W2310231512","https://openalex.org/W2066975798","https://openalex.org/W4247911877"],"abstract_inverted_index":{"AIM:":[0],"The":[1],"purposes":[2],"of":[3,12,56,183],"our":[4],"study":[5],"were":[6,61,77],"to":[7,34,83,121,181],"compare":[8],"the":[9,40,129,169],"clinical":[10],"outcomes":[11],"human":[13],"epidermal":[14],"growth":[15],"factor":[16],"receptor":[17,136],"2":[18],"(HER2)-positive":[19],"metastatic":[20],"breast":[21,49],"cancer":[22],"(mBC)":[23],"patients":[24,58,68,92,107,133,184],"with":[25,44,59,72,93,134,162,185],"or":[26,73,94,146],"without":[27,74,95],"trastuzumab":[28,45,88,96],"treatment":[29,46,97],"and":[30,33,87,98,119,190],"HER2-negative":[31,99,186],"patients,":[32,175],"explore":[35],"factors":[36],"that":[37,182,198],"might":[38,193],"predict":[39,199],"survival":[41,111,158,171,200],"benefit":[42,159,201],"associated":[43],"in":[47,63,104,125,172],"HER2-positive":[48,90,105,132,173],"cancer.":[50],"PATIENTS":[51],"AND":[52],"METHODS:":[53],"A":[54],"total":[55],"421":[57],"mBC":[60,91,106,174],"analyzed":[62],"this":[64],"retrospective":[65],"study.":[66],"All":[67],"had":[69,156],"first-line":[70],"chemotherapy":[71],"trastuzumab.":[75,163],"They":[76],"classified":[78],"into":[79],"3":[80],"groups":[81],"according":[82],"their":[84],"HER2":[85],"status":[86,138,189],"treatment:":[89],"patents.":[100],"RESULTS:":[101],"Trastuzumab":[102,165],"administration":[103,166],"significantly":[108,167],"prolonged":[109],"overall":[110,170],"(33":[112],"vs.":[113,140,150],"26":[114],"months;":[115,142,152],"P":[116,143,153],"=":[117,144,154],"0.003)":[118],"led":[120],"a":[122,178],"49.8%":[123],"reduction":[124],"death":[126],"risk.":[127],"In":[128],"subgroup":[130],"analysis,":[131],"hormone":[135],"(HR)-negative":[137],"(29":[139],"17":[141],"0.000)":[145,155],"visceral":[147],"metastasis":[148,191],"(30":[149],"21":[151],"more":[157],"when":[160],"treated":[161],"CONCLUSIONS:":[164],"improved":[168],"who":[176],"gained":[177],"prognosis":[179],"comparable":[180],"disease.":[187],"HR":[188],"site":[192],"be":[194],"important":[195],"surrogate":[196],"makers":[197],"from":[202],"trastuzumab-based":[203],"treatment.":[204]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-21T00:00:00"}